alexa

GET THE APP

Outcome of Patients on Second Line of Antiretroviral Therapy in Dakar | OMICS International| Abstract
ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • J Infect Dis Ther,
  • DOI: 10.4172/2332-0877.1000412

Outcome of Patients on Second Line of Antiretroviral Therapy in Dakar

Louise Fortes1*, Khardiata Diallo Mbaye1, Agbogbenkou Tévi Déla Lawson2, Viviane Marie Pierre Cisse Diallo1, Joubaly Zeina1, Ndeye Aïssatou Lakhe1, Daye Ka1, Assane Diouf1, Ndeye Fatou Ngom Guèye3, Cheikh Tacko Diop3, Massaly Aminata1, Allasane Dieye1, Sylvie Diop-Nyafouna2, Cheikh Tidiane Ndour1 and Moussa Seydi1
1Department of Infectious and Tropical Diseases, University Hospital Center of Fann, Dakar, Senegal
2Department of UFR de Santé de Thies, Thies, Senegal
3Department of Alioune Diop University of Bambey, Bambey, Senegal
*Corresponding Author : Louise Fortes, Department of Infectious and Tropical Diseases, Fann University Hospital, Dakar, Senegal, Tel: +00221775595333, Email: [email protected]

Received Date: Nov 11, 2019 / Accepted Date: Nov 24, 2019 / Published Date: Dec 02, 2019

Abstract

Context: In resource-limited countries, late start of antiretroviral treatment, lack of compliance and limited access to viral load testing are all factors that contribute to the increase in the number of second-line patients. Despite this situation, treatment options remain limited in our countries. The objectives of this study were to describe the characteristics of patients and to evaluate the outcome of HIV-1 infected patients undergoing second-line ARV treatment.

Methods: Retrospective cohort study conducted at the Department of Infectious and Tropical Diseases (SMIT) of the National University Hospital Centre (CHNU) of Fann in Dakar. HIV-1 infected patients on second-line ARV treatment between January 1, 2008 and December 31, 2016 were included. The data was collected from the medical records and analysed with the Info version 7 software.

Results: In our study, we included 135 patients. The median time to switch from the first to the second line of antiretroviral treatment was 3 years [2.5-5.5]. The average age was 41.7 ± 10.4 years at the start of the second ARV treatment line. The sex ratio (F/H) was 1.4. At the start of ART, 107 (79.3%) were classified as WHO stage 3 and 4 whereas this proportion was 21.5% at the time of the change of treatment. Including the second line, the median CD4+ T cell count was 122/mm3 (48-223) and after 12 months of treatment, the increase in CD4+ count was on average 208 cells/mm3. When switching to a different antiretroviral treatment, viral load was available in one third of the cases (31.8%) and the median rate was 79 900[17773-21000000] copies/ml. The most commonly used second line protocols were TDF+3TC+LPV/r (35.6%) followed by ABC+DDI+LPV/r (18.5%). Regarding the patients ’ outcomes, 13 (9.6%) died and the rate of patients lost to follow-up was 23% after a median follow-up time of 3 years (1-4.5). The median duration of second-line follow-up was 4 years (1.5-6).

Conclusion: Upon initiation of the second-line, few patients had clinical failure. However, the change in treatment remains late because the CD4+ rate was low. Treatment progress is satisfactory on average due to the high rate of lost to follow-up patients. Active research of patients should be strengthened in order to improve the second-line patient monitoring.

Keywords: Second line; Antiretroviral; Therapy; Dakar

Citation: Fortes L, Mbaye DK, Lawson TAD, Diallo VPC, Joubaly Z, et al. (2019) Outcome of Patients on Second Line of Antiretroviral Therapy in Dakar. J Infect Dis Ther 7: 412. Doi: 10.4172/2332-0877.1000412

Copyright: © 2019 Fortes L, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Recommended Conferences
Article Usage
  • Total views: 215
  • [From(publication date): 0-0 - Jul 31, 2021]
  • Breakdown by view type
  • HTML page views: 132
  • PDF downloads: 83
Top